Latest filing published 07 Aug 2023 for TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED, €3.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +18.0%Entry US$1.94 · Close at T+365 US$2.29
- +12.2%Entry US$1.97 · Close at T+365 US$2.21
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tianjin Bohai Guoxin Technology Co., Ltd.: trading record in brief
This profile gathers the share dealings of Tianjin Bohai Guoxin Technology Co., Ltd. in Tianjin Pharmaceutical da REN Tang Group Corporation Limited. The record holds 2 filings, for trades running from 4 August 2023 to 7 August 2023.
Purchases make up the whole of the open-market record (2 purchases, €5). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
Most recently, on 7 August 2023, the filings show an open-market purchase worth €3 in Tianjin Pharmaceutical da REN Tang Group Corporation Limited. This summary is built from SGX disclosures alone and does not predict where the share price will go.
Companies and markets linked to Tianjin Bohai Guoxin Technology Co., Ltd.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4 shares@ SGD 1.0049.9% of flowShareSGX-STISIN CNE100000924SGX:TZPWDQBJ5OLE2C6HCanonical exit: 5 Nov 2023 (T+90)
- 4 shares@ SGD 1.0050.1% of flowShareSGX-STISIN CNE100000924SGX:E2OWP642M8L85M3DCanonical exit: 2 Nov 2023 (T+90)
2 of 2 declarations